tiprankstipranks
Advertisement
Advertisement

ENTA Stock Latest News

Enanta Pharmaceuticals Establishes Flexible At-The-Market Offering
Company AnnouncementsEnanta Pharmaceuticals Establishes Flexible At-The-Market Offering
19d ago
8K
ENTA
Enanta Faces Patent Setback in Paxlovid Litigation
PremiumCompany Announcements
Enanta Faces Patent Setback in Paxlovid Litigation
28d ago
8K
ENTA
Enanta announces European Commission approval of Maviret
PremiumThe Fly
Enanta announces European Commission approval of Maviret
28d ago
ENTA
Enanta Advances RSV Antiviral Zelicapavir to Registrational Trial
PremiumCompany Announcements
Enanta Advances RSV Antiviral Zelicapavir to Registrational Trial
1M ago
8K
ENTA
Enanta to advance zelicapavir into registrational Phase 2b/3 clinical trial
PremiumThe Fly
Enanta to advance zelicapavir into registrational Phase 2b/3 clinical trial
1M ago
ENTA
Enanta reports Q2 EPS (45), consensus (49c)
PremiumThe FlyEnanta reports Q2 EPS (45), consensus (49c)
2M ago
ENTA
ENTA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ENTA Earnings this Week: How Will it Perform?
2M ago
ENTA
Enanta announces first participant dosed in Phase 1 trial of EDP-978
Premium
The Fly
Enanta announces first participant dosed in Phase 1 trial of EDP-978
3M ago
ENTA
Enanta Advances Federal Circuit Appeal in Paxlovid Patent Case
PremiumCompany Announcements
Enanta Advances Federal Circuit Appeal in Paxlovid Patent Case
4M ago
8K
ENTA
Enanta initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
Enanta initiated with a Buy at Rodman & Renshaw
4M ago
ENTA
Enanta’s New RSV Trial in Infants: What Investors Should Watch in ENTA
PremiumCompany Announcements
Enanta’s New RSV Trial in Infants: What Investors Should Watch in ENTA
4M ago
ENTA
Enanta Shareholders Approve Board Elections and Equity Plan
PremiumCompany Announcements
Enanta Shareholders Approve Board Elections and Equity Plan
4M ago
8K
ENTA
Enanta Pharmaceuticals: RSV Monoclonal Headwinds Turn Tailwind for Zelicapavir Treatment Opportunity
PremiumRatingsEnanta Pharmaceuticals: RSV Monoclonal Headwinds Turn Tailwind for Zelicapavir Treatment Opportunity
5M ago
ENTA
Enanta files $150M mixed securities shelf
Premium
The Fly
Enanta files $150M mixed securities shelf
5M ago
ENTA
Enanta reports Q1 EPS (42c), consensus (88c)
Premium
The Fly
Enanta reports Q1 EPS (42c), consensus (88c)
5M ago
ENTA
Enanta Pharmaceuticals (ENTA) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Enanta Pharmaceuticals (ENTA) Q1 Earnings Cheat Sheet
5M ago
ENTA
Enanta Pharmaceuticals: Promising Pipeline and Strong Financial Position Justify Buy Rating
PremiumRatings
Enanta Pharmaceuticals: Promising Pipeline and Strong Financial Position Justify Buy Rating
8M ago
ENTA
Enanta Pharmaceuticals Reports Progress in Drug Development
PremiumCompany Announcements
Enanta Pharmaceuticals Reports Progress in Drug Development
8M ago
ENTA
Enanta reports Q4 EPS (87c), consensus ($1.01)
PremiumThe Fly
Enanta reports Q4 EPS (87c), consensus ($1.01)
8M ago
ENTA
Is ENTA a Buy, Before Earnings?
PremiumPre-EarningsIs ENTA a Buy, Before Earnings?
8M ago
ENTA
Buy Rating for Enanta Pharmaceuticals Driven by Promising RSV Drug Pipeline and Market Potential
Premium
Ratings
Buy Rating for Enanta Pharmaceuticals Driven by Promising RSV Drug Pipeline and Market Potential
8M ago
ENTA
Enanta initiated with an Overweight at JPMorgan
Premium
The Fly
Enanta initiated with an Overweight at JPMorgan
8M ago
ENTA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >